tiprankstipranks
Trending News
More News >
Barinthus Biotherapeutics Plc (BRNS)
NASDAQ:BRNS
US Market

Barinthus Biotherapeutics (BRNS) Income Statement

Compare
104 Followers

Barinthus Biotherapeutics Income Statement

Last quarter (Q3 2025), Barinthus Biotherapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Barinthus Biotherapeutics's net income was $-14.57M. See Barinthus Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 14.97M$ 802.00K$ 44.70M$ 268.00K$ 4.82M
Gross Profit
$ 14.97M$ 802.00K$ 44.70M$ 268.00K$ -9.57M
Operating Expenses
$ 82.94M$ 84.72M$ 48.74M$ 45.49M$ 10.48M
Depreciation and Amortization
$ 5.80M$ 5.43M$ 4.32M$ 602.00K$ 208.00K
EBITDA
$ -55.37M$ -71.06M$ 5.19M$ -47.87M$ -16.56M
Operating Income
$ -67.97M$ -83.91M$ -4.04M$ -45.22M$ -20.05M
Other Income/Expenses
$ 6.74M$ 7.39M$ 4.89M$ -5.92M$ 2.21M
Pretax Income
$ -61.23M$ -76.52M$ 850.00K$ -51.14M$ -17.84M
Net Income
$ -61.07M$ -73.35M$ 5.34M$ -50.87M$ -17.71M
Per Share Metrics
Basic EPS
$ -1.55$ -1.91$ 0.14$ -1.37$ -2.24
Diluted EPS
$ -1.55$ -1.91$ 0.14$ -1.37$ -2.24
Weighted Average Shares Outstanding
39.35M 38.39M 37.25M 37.19M 7.90M
Weighted Average Shares Outstanding (Diluted)
39.35M 38.39M 38.17M 37.19M 7.90M
Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History